EUROFINS SCIENT. news, videos and press releases - Page 3
For more news please use our advanced search feature.
EUROFINS SCIENT. - More news...
EUROFINS SCIENT. - More news...
- Eurofins Genoma Announces Launch of niPGT-A, a Non-Invasive, Embryo Biopsy Free, Preimplantation Genetic Aneuploidy Screening Test
- Eurofins Sacramento, in Collaboration with SCIEX USA, Achieves the Lowest Detection Limits for PFAS in Drinking Water
- Eurofins Sustainability Solutions Launched
- Eurofins divests its Digital Testing business
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 August 2022
- Eurofins Strengthens Its Comprehensive Food Testing Offering in Japan Through the Acquisition of QSAI Analysis and Research Center Co.,Ltd.
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 July 2022
- Eurofins Enhances Its Environmental, Food and BioPharma Product Testing Offering in Hungary Through the Acquisition of WESSLING Hungary
- Eurofins Posts Record Revenues of €3,412m and Overall Results Well in Excess of Its Objectives in H1 2022 and Increases Its Objectives for H2 and FY 2022
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 June 2022
- Eurofins Announces the Success of Its Tender Offers on Its Existing Hybrid Bonds
- Gold Standard Diagnostics, a Eurofins Technologies Company, Announces a PCR Assay for the Detection of the Monkeypox and Orthopox Virus
- Eurofins Successfully Prices New €600m 7-Year 4%-Coupon Senior Unsecured Bonds
- Eurofins Announces Its Intention to Issue New Euro Senior Bonds to Refinance Part of Its Existing Hybrid Bonds
- Eurofins Built Environment Testing Expands AIHA LAP, LLC Certification for Industrial Hygiene Analysis
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 May 2022
- Eurofins to Acquire Majority Stake in Ajal for Laboratories, to Expand its Food and Pharmaceutical Products Testing Offering in the Kingdom of Saudi Arabia
- Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.
- Nation’s PFAS Testing Leader, Eurofins Environment Testing USA, One of the First Commercial Laboratories to receive Accreditation for Draft Method 1633
- Health Canada approves Eurofins CDMO Alphora Inc.’s Standard Processing License for Synthetic Phytocannabinoids
- PAMM Foundation Outsources Its Laboratory Activities for Pathology and Medical Microbiology (“PAMM”) to Eurofins Clinical Diagnostics Netherlands
- PAMM Foundation Outsources Its Laboratory Activities for Pathology and Medical Microbiology (“PAMM”) to Eurofins Clinical Diagnostics Netherlands
- CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022
- Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022
- Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022
- Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023
- Eurofins to Acquire Genetic Testing Service JSC and Enter the Clinical Genetic Testing Market in Vietnam